Marcela Santos Cavalcanti

Marcela Santos Cavalcanti

Auto-generated profile, based on publicly available information

Marcela Santos Cavalcanti

Faculdade Evangélica Mackenzie do Paraná, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2022 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
AVA. Vaz
A. Vaz
MCM.S. Cavalcanti
M.S. Cavalcanti
EJErasmo Barros da Silva Jr
Erasmo Barros da Silva Jr
RRR. Ramina
R. Ramina
BTBernardo Correa de Almeida Teixeira
Bernardo Correa de Almeida Teixeira
SUMMARY: Glioneuronal tumors are characterized exclusively by neurocytic elements (neuronal tumors) or a combination of neuronal and glial features (mixed neuronal-glial tumors). Most of these tumors occur in young patients and are related to epilepsy. While ganglioglioma, dysembryoplastic neuroepithelial tumor, and desmoplastic infantile tumor are common glioneuronal tumors, anaplastic ganglioglioma, papillary glioneuronal tumor, rosette-forming glioneuronal tumor, gangliocytoma, and central neurocytoma are less frequent. Advances in immunohistochemical and molecular diagnostics have improved the characterization of these tumors and favored the description of variants and new subtypes, some not yet classified by the World Health Organization. Not infrequently, the histologic findings of biopsies of glioneuronal tumors simulate low-grade glial neoplasms; however, some imaging findings favor the correct diagnosis, making neuroimaging essential for proper management. Therefore, the aim of this review was to present key imaging, histopathology, immunohistochemistry, and molecular findings of glioneuronal tumors and their variants.

4 January 2022 in Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery
Verified
Journal Article
Open access
PDF file
EJErasmo Barros da Silva Jr
Erasmo Barros da Silva Jr
RRRicardo Ramina
Ricardo Ramina
MNMaurício Coelho Neto
Maurício Coelho Neto
GMGuilherme Augusto de Souza Machado
Guilherme Augusto de Souza Machado
MCMarcella Santos Cavalcanti
Marcella Santos Cavalcanti
JSJoseph Franklin Chenisz da Silva
Joseph Franklin Chenisz da Silva
Introduction Fluorescence guidance with 5-aminolevulinic acid (5-ALA) is a safe and reliable tool in total gross resection of intracranial tumors, especially malignant gliomas and cases of metastasis. In the present retrospective study, we have analyzed 5-ALA-induced fluorescence findings in different central nervous system (CNS) lesions to expand the indications of its use in differential diagnoses. Objectives To describe the indications and results of 5-ALA fluorescence in a series of 255 cases. Methods In 255 consecutive cases, we recorded age, gender, intraoperative 5-ALA fluorescence tumor response, and 5-ALA postresection status, as well the complications related to the method. Postresection was classified as ‘5-ALA free’ or ‘5-ALA residual’. The diagnosis of histopathological tumor was established according to the current classification of the World Health Organization (WHO). Results There were 195 (76.4%) 5-ALA positive cases, 124 (63.5%) of whom underwent the ‘5-ALA free’ resection. The findings in the positive cases were: 135 gliomas of all grades; 19 meningiomas; 4 hemangioblastomas; 1 solitary fibrous tumor; 27 metastases; 2 diffuse large B cell lymphomas; 2 cases of radionecrosis; 1 inflammatory disease; 2 cases of gliosis; 1 cysticercosis; and 1 immunoglobulin G4-related disease. Conclusion Fluorescence with 5-ALA can be observed in lesions other than malignant gliomas or metastases, including meningiomas, hemangioblastomas, pilocytic astrocytomas, and lymphomas. Although there is need for further evidence for the use of 5-ALA beyond high-grade gliomas, it may be a safe and reliable tool to improve resection in positive tumors or to guide the histopathologic analysis in biopsies.

17 March 2022 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
DGDouglas Mesadri Gewehr
Douglas Mesadri Gewehr
ANAlan Neiverth
Alan Neiverth
MCMarcela Santos Cavalcanti
Marcela Santos Cavalcanti
TMThiago Ceschin Maestri
Thiago Ceschin Maestri
SHSemi Haurani
Semi Haurani
LKLuiz Fernando Kubrusly
Luiz Fernando Kubrusly
Primary cardiac tumors are rare, with an incidence between 0.0017 and 0.19%, and are asymptomatic in up to 72% of cases. Approximately 75% of tumors are benign, and nearly 50% of these are myxomas. Concerning location, 75% of myxomas are in the left atrium, 15 to 20% in the right atrium, and more rarely in the ventricles. The finding of cardiac myxomas usually implies immediate surgical excision to prevent embolic events and sudden cardiac death. Reports with documented growth

23 March 2023 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
FSF. Sprenger
F. Sprenger
EJErasmo Barros da Silva Jr
Erasmo Barros da Silva Jr
MCM.S. Cavalcanti
M.S. Cavalcanti
BTBernardo Correa de Almeida Teixeira
Bernardo Correa de Almeida Teixeira
SUMMARY: Astroblastoma is a rare astrocytic glial neoplasm that affects mainly young girls, peaking between 10 and 30 years of age, with low- and high-grade manifestations. Imaging characteristics are well-described, but histopathologic and, more recently, molecular analysis is fundamental to establish the diagnosis, now based on MN1 alterations. We describe a case with typical imaging and histologic features of an MN1-altered astroblastoma.

1 January 2021 in Urology Case Reports
Verified
Journal Article
Open access
ECEurico Cleto Ribeiro de Campos
Eurico Cleto Ribeiro de Campos
MJMarcos Gonçalves Adriano Júnior
Marcos Gonçalves Adriano Júnior
MWMarcus Rivabem Winheski
Marcus Rivabem Winheski
SMSamya Hamad Mehanna
Samya Hamad Mehanna
MCMarcela Santos Cavalcanti
Marcela Santos Cavalcanti
RMRenan Martins
Renan Martins
Renal Cell Carcinoma (RCC) corresponds to 3% of the neoplasms in the adults. Surgery is the main mode of treatment, which can be associated toretroperitoneal lymphadenectomy in the presence of clinically tumor positive lymph nodes. Castleman Disease (CD) is a rare lymphoproliferative disorder, with little-known etiopathogenesis. It rarely affects the retroperitoneum. Thorax, neck, and abdomen are more frequently affected. Therefore, CD can simulate lymphatic spread from RCC to the retroperitoneum, also leading to a possible misdiagnosis, or diagnosis concerning a paraneoplastic syndrome due to RCC.

1 January 2025 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
ESEmily Karoline Araujo Nonato dos Santos
Emily Karoline Araujo Nonato dos Santos
BTBruna Gama Triches
Bruna Gama Triches
GSGuilherme Prestes da Silva
Guilherme Prestes da Silva
JLJulia Costa Linhares
Julia Costa Linhares
SMSamya Hamad Mehanna
Samya Hamad Mehanna
MCMarcela Santos Cavalcanti
Marcela Santos Cavalcanti
BACKGROUND: Microscopic analysis of tumor budding (TB) may be an essential predictive tool for regional lymph node metastases in colorectal cancer, especially among patients in intermediate stages, who exhibit considerable prognostic variability.